Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wakeen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Public Health Dentistry|January 1, 1992
Legal implications of using drugs and devices in the dental officeL M Wakeen
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 18, 1998
Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysisM Wakeen, S W Zimmerman
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 1, 1997
Characteristics of long-term peritoneal dialysis survivors: 18 years experience in one centerE M Abdel-Rahman, M Wakeen, S W Zimmerman
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Long-term outcome of diabetic patients receiving peritoneal dialysisS W Zimmerman, L L Oxton, D Bidwell, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1994
Risk factors for peritoneal dialysis-related infectionsL L Oxton, S W Zimmerman, E B Roecker, et al.
Advances in Renal Replacement Therapy|April 1, 1994
Renal replacement therapy in diabetic nephropathyS W Zimmerman, H Sollinger, M Wakeen, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 21, 2000
Comparison of intraperitoneal and subcutaneous epoetin alfa in peritoneal dialysis patientsC A Johnson, M Wakeen, C A Taylor, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Public Health Dentistry|January 1, 1992
Legal implications of using drugs and devices in the dental officeL M Wakeen
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 18, 1998
Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysisM Wakeen, S W Zimmerman
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 1, 1997
Characteristics of long-term peritoneal dialysis survivors: 18 years experience in one centerE M Abdel-Rahman, M Wakeen, S W Zimmerman
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Long-term outcome of diabetic patients receiving peritoneal dialysisS W Zimmerman, L L Oxton, D Bidwell, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1994
Risk factors for peritoneal dialysis-related infectionsL L Oxton, S W Zimmerman, E B Roecker, et al.
Advances in Renal Replacement Therapy|April 1, 1994
Renal replacement therapy in diabetic nephropathyS W Zimmerman, H Sollinger, M Wakeen, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 21, 2000
Comparison of intraperitoneal and subcutaneous epoetin alfa in peritoneal dialysis patientsC A Johnson, M Wakeen, C A Taylor, et al.
Pageof 1